Fractional flow reserve derived from coronary computed tomography angiography enables noninvasive assessment of the hemodynamic significance of coronary artery lesions and coupling of the anatomic severity of a coronary stenosis with its physiological effects. Since its initial demonstration of feasibility of use in humans in 2011, a significant body of clinical evidence has developed to evaluate the diagnostic performance of coronary computed tomography angiography-derived fractional flow reserve compared with an invasive fractional flow reserve reference standard. The purpose of this paper was to describe the scientific principles and to review the clinical data of this technology recently approved by the U.S.
(an inadequacy of myocardial oxygen for a given metabolic state) and has never been validated in a human model. Although reductions in CFR manifest generally predictable reductions at hyperemic flow states for coronary stenosis $70%, the relationship between coronary stenosis and myocardial ischemia is nevertheless complex. Approximately 1 in 5 high-grade lesions with $70% stenosis do not cause ischemia, and diminution of coronary flow can begin as early as 40% diameter stenosis or in the context of diffuse or serial "nonobstructive" stenosis (5) . Furthermore, CFR accounts for abnormalities across the entirety of the coronary vascular bed, which includes not only the epicardial coronary arteries but also the intramyocardial pre-arteriolar, arteriolar, and capillary circulations (6) . Precise localization of CFR abnormalities to the epicardial versus nonepicardial vessels is vital, given that effective treatments exist for the former (including both medical therapy and revascularization), but no known effective treatments exist for the latter. Recently, coronary computed tomography angiography (CTA) has been offered as an anatomic alternative to stress imaging testing (1) . Based on several prospective multicenter studies, coronary CTA exhibits high diagnostic performance for the identification and exclusion of anatomically obstructive coronary stenosis compared with an ICA reference standard. Coronary CTA findings are prognostically important and serve as effective guides toward medical and invasive management. However, similar to limitations of CFR that manifest a generally weak association with ischemia, and further emphasizing the complex relationship between stenosis and flow, coronary CTA has exhibited low specificity for identification of ischemia-causing coronary stenosis (10) .
Indeed, >50% of lesions considered anatomically obstructive according to coronary CTA do not cause ischemia. These findings are not singular to coronary CTA but are observed uniformly for all anatomic methods of coronary imaging, including ICA and intravascular ultrasound.
INVASIVE FRACTIONAL FLOW RESERVE
Fractional flow reserve (FFR) performed at the time of ICA for combined anatomic-physiological evaluation represents the current gold standard for determining whether a coronary artery stenosis causes ischemia (11) . FFR is defined as the ratio of maximal hyperemic flow to part of the myocardium in the presence of a stenosis in the supplying epicardial artery to the maximum hyperemic flow to the same myocardial territory in the hypothetical case in which the supplying artery is normal. An FFR #0.80 (i.e., when the distal coronary pressure is 80% of the aortic pressure under conditions of maximal hyperemia) is commonly accepted as the threshold below which a lesion is considered ischemia causing. Deferral of percutaneous coronary intervention (PCI) for vessels with an FFR >0.80 is associated with improved clinical outcomes and reduced costs compared with an ICA alone-guided intervention (12) . Conversely, coronary revascularization in vessels with a measured FFR #0.80 is associated with reduced risk of death, myocardial infarction, or urgent revascularization compared with an ICA alone-guided revascularization or optimal medical therapy (OMT) alone (13, 14) . Based on these and other data, current guidelines regarding myocardial revascularization assign a Class IA recommendation to FFR for the assessment of coronary artery stenoses with a diameter reduction ranging from 50% to 90% unless there is noninvasive proof of ischemia (15) . This figure demonstrates several of the important components of FFR CT . As can be seen, patient-specific geometry from coronary computed tomography allows for accurate segmentation of coronary artery geometry. Each of these coronary artery segments undergoes mesh segmentation and the governing equations of fluid dynamics are solved for each of these meshes to calculate FFR CT within the entire vascular bed. Coupling arterial form with myocardial mass enables calculation of relative myocardial blood flow. FFR CT ¼ coronary computed tomography angiography-derived fractional flow reserve. As shown in Figure 1F , the form-function relat- in the DeFACTO study, in which a >2-fold increase in sensitivity was observed for FFR CT over coronary CTA stenosis alone (82% vs. 37%), with no compromise in specificity ( Figure 2C ) (34). In the NXT study, improved specificity of FFR CT compared with coronary CTA was observed (79% vs. 32%; p < 0.0001), with no differences in sensitivity (85% vs. 93%).
The diagnostic accuracy of FFR CT and coronary CTA was compared for ischemia evaluation in patients with severely elevated coronary artery calcium scores >400 (Figure 2A ). In the NXT trial, per-patient accuracy and specificity were higher for FFR CT than for coronary CTA (75% vs. 44% and 69% vs. 23%
[both p < 0.0001]), with no sacrifice in sensitivity.
These findings were in accordance with those observed in the DeFACTO trial.
To date, no FFR CT study has been reported that examines its diagnostic performance in a myriad of patient cohorts, which may display important Consistent among the DISCOVER-FLOW, DeFACTO, and NXT trials was an observed improvement in overall diagnostic accuracy that stemmed from a significant reduction in "false-positive" coronary CTA studies, wherein a stenosis was considered highgrade, but lesion-specific ischemia was not present.
However, there were also numerous findings related to image acquisition protocols, image quality, and Only future studies examining the relationship of FFR CT to these data will reveal its precise role in clinical practice.
In addition to these diagnostic features, FFR CT has been shown capable of identifying ischemia which stem from coronary lesions that do not meet conventional definitions of "angiographically severe"
(i.e., intermediate stenoses, diffuse atherosclerosis) ( Figure 2B ) and small vessels demonstrating inadequate vasodilation. Finally, FFR CT has the potential to predict the therapeutic benefit of coronary revascularization by "virtual stenting" or even the relative efficacy of revascularization strategy ( Figure 2E ). As an example of the latter, multivessel virtual stenting may be compared with "virtual bypass surgery" by using FFR CT to determine which method maximally reduces ischemia ( Figure 2D 
